FUCHS HENRY J
Insider CIK 1197355 · BMRN President, Worldwide R&D · RDEA Director · GHDX Director · MRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-09-13 | 2024-09-17 | 12,098 | $84.90 | $1.03M | 185,074 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-04-30 | 2024-09-17 | 300 | $68.65 | $20.6K | 197,172 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2024-03-15 | 2024-03-19 | 40,860 | — | $0 | 40,860 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-03-15 | 2024-03-19 | 18,240 | — | $0 | 230,357 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-03-15 | 2024-03-19 | 33,485 | $83.87 | $2.81M | 196,872 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-03-05 | 2024-03-07 | 35,341 | $85.18 | $3.01M | 212,117 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 13,326 | — | $0 | 238,220 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 9,238 | — | $0 | 247,458 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 30,640 | — | $0 | 224,894 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-12-01 | 2023-12-05 | 17,750 | — | $0 | 194,254 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-08-10 | 2023-08-11 | 12,000 | $90.43 | $1.09M | 176,187 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-04-28 | 2023-12-05 | 317 | $66.88 | $21.2K | 176,504 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-16 | 2023-03-17 | 36,000 | $93.41 | $3.36M | 188,187 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-03-15 | 2023-03-17 | 38,450 | — | $0 | 38,450 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-03-15 | 2023-03-17 | 16,840 | — | $0 | 228,986 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-15 | 2023-03-17 | 4,799 | $87.74 | $421.1K | 224,187 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 18,220 | — | $0 | 198,754 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 36,440 | — | $0 | 180,534 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 13,392 | — | $0 | 212,146 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 7,520 | — | $0 | 7,520 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 4,444 | — | $0 | 10,465 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-16 | 2022-03-17 | 2,259 | $80.72 | $182.3K | 143,753 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2022-03-15 | 2022-03-17 | 35,830 | — | $0 | 35,830 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-15 | 2022-03-17 | 12,101 | $78.27 | $947.1K | 146,012 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-15 | 2022-03-17 | 38,790 | — | $0 | 158,113 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-08 | 2022-03-10 | 12,840 | — | $0 | 119,323 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2022-02-11 | 2022-02-14 | 5,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2022-02-11 | 2022-02-14 | 6,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2022-02-11 | 2022-02-14 | 6,000 | $20.54 | $123.2K | 12,021 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-14 | 2,090 | $104.76 | $218.9K | 14,931 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2022-02-11 | 2022-02-14 | 5,000 | $20.54 | $102.7K | 17,021 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-14 | 8,700 | $105.80 | $920.5K | 6,231 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-14 | 210 | $106.34 | $22.3K | 6,021 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 3,688 | — | $0 | 3,688 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 2,546 | — | $0 | 6,021 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-22 | 2021-03-23 | 2,454 | $78.52 | $192.7K | 106,142 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-16 | 2021-03-17 | 2,259 | $77.21 | $174.4K | 108,596 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2021-03-15 | 2021-03-17 | 37,710 | — | $0 | 37,710 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-15 | 2021-03-17 | 7,460 | $78.39 | $584.8K | 110,855 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-03-15 | 2021-03-17 | 15,320 | — | $0 | 118,315 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 2,155 | — | $0 | 2,155 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 1,475 | — | $0 | 3,475 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-12-15 | 2020-12-16 | 10,000 | — | $0 | 6,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 40 | $237.90 | $9.5K | 2,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-12-15 | 2020-12-16 | 10,000 | $20.54 | $205.4K | 12,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 1,218 | $230.19 | $280.4K | 10,782 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 1,399 | $232.01 | $324.6K | 9,383 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 4,461 | $233.40 | $1.04M | 4,922 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 610 | $234.27 | $142.9K | 4,312 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 1,821 | $235.19 | $428.3K | 2,491 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 451 | $237.36 | $107.0K | 2,040 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-08-10 | 2020-08-11 | 10,000 | — | $0 | 5,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-10 | 2020-08-11 | 500 | $133.07 | $66.5K | 2,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-10 | 2020-08-11 | 5,800 | $132.34 | $767.6K | 2,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-10 | 2020-08-11 | 1,300 | $131.08 | $170.4K | 8,300 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-10 | 2020-08-11 | 1,000 | $129.80 | $129.8K | 9,600 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-10 | 2020-08-11 | 900 | $128.56 | $115.7K | 10,600 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-10 | 2020-08-11 | 500 | $127.52 | $63.8K | 11,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-08-10 | 2020-08-11 | 10,000 | $20.54 | $205.4K | 12,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-07-20 | 2020-07-22 | 49,423 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-07-20 | 2020-07-22 | 75,716 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-07-20 | 2020-07-22 | 1,250 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-07-20 | 2020-07-22 | 126,389 | $130.00 | $16.43M | 102,995 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-07-20 | 2020-07-22 | 49,423 | $63.10 | $3.12M | 229,384 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-07-20 | 2020-07-22 | 1,250 | $67.81 | $84.8K | 104,245 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-07-20 | 2020-07-22 | 75,716 | $67.81 | $5.13M | 179,961 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-07-13 | 2020-07-15 | 8,977 | — | $0 | 49,423 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-07-13 | 2020-07-15 | 224 | — | $0 | 1,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-07-13 | 2020-07-15 | 13,810 | — | $0 | 75,716 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-07-13 | 2020-07-15 | 23,011 | $130.00 | $2.99M | 102,995 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-07-13 | 2020-07-15 | 8,977 | $63.10 | $566.4K | 126,006 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-07-13 | 2020-07-15 | 224 | $67.81 | $15.2K | 103,219 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-07-13 | 2020-07-15 | 13,810 | $67.81 | $936.5K | 117,029 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-04-30 | 2020-07-15 | 339 | $62.59 | $21.2K | 102,995 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-24 | 2020-04-28 | 13,642 | $95.34 | $1.30M | 109,014 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-24 | 2020-04-28 | 3,678 | $96.85 | $356.2K | 105,336 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-24 | 2020-04-28 | 2,680 | $97.32 | $260.8K | 102,656 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-20 | 2020-04-22 | 17,213 | $90.00 | $1.55M | 122,656 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-20 | 2020-03-24 | 5,836 | $73.05 | $426.3K | 139,869 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2020-03-16 | 2020-03-17 | 51,970 | — | $0 | 51,970 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-16 | 2020-03-17 | 18,220 | — | $0 | 145,705 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-13 | 2020-03-17 | 10,496 | $84.50 | $886.9K | 127,485 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-03 | 2020-03-04 | 13,136 | — | $0 | 137,981 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-07 | 2,000 | — | $0 | 2,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 6,583 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer deriv | 2019-11-08 | 2019-11-14 | 10,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer | 2019-11-08 | 2019-11-14 | 6,878 | — | $0 | 955 | SEC↗ |
| GHDX GENOMIC HEALTH INC | D To issuer | 2019-11-08 | 2019-11-14 | 955 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-10-01 | 2019-10-03 | 185 | $67.28 | $12.4K | 7,833 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-07-01 | 2019-07-03 | 212 | $58.86 | $12.5K | 7,648 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2019-06-14 | 2019-06-18 | 6,583 | — | $0 | 6,583 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-06-14 | 2019-06-18 | 955 | — | $0 | 7,436 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-04-30 | 2019-06-07 | 309 | $68.78 | $21.3K | 124,845 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-04-01 | 2019-04-03 | 149 | $66.84 | $10.0K | 6,481 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-25 | 2019-03-26 | 5,932 | $87.86 | $521.2K | 124,536 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-22 | 2019-03-26 | 5,836 | $88.05 | $513.9K | 130,468 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-18 | 2019-03-19 | 9,597 | $94.09 | $903.0K | 136,304 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2019-03-15 | 2019-03-19 | 32,160 | — | $0 | 32,160 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-15 | 2019-03-19 | 9,443 | $94.53 | $892.6K | 133,061 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-15 | 2019-03-19 | 12,840 | — | $0 | 145,901 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-04 | 2019-03-06 | 2,196 | $95.00 | $208.6K | 142,504 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-01 | 2019-03-05 | 15,687 | — | $0 | 145,854 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-01 | 2019-03-05 | 1,154 | $94.76 | $109.4K | 144,700 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2019-02-25 | 2019-02-26 | 3,521 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2019-02-25 | 2019-02-26 | 3,000 | $78.88 | $236.6K | 6,853 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2019-02-25 | 2019-02-26 | 521 | $79.80 | $41.6K | 6,332 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2019-02-25 | 2019-02-26 | 3,521 | $27.75 | $97.7K | 9,853 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2019-02-22 | 2019-02-26 | 20,000 | — | $0 | 0 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise deriv | 2019-02-22 | 2019-02-26 | 6,479 | — | $0 | 3,521 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2019-02-22 | 2019-02-26 | 20,000 | $33.67 | $673.4K | 26,332 | SEC↗ |
| GHDX GENOMIC HEALTH INC | M Exercise | 2019-02-22 | 2019-02-26 | 6,479 | $27.75 | $179.8K | 32,811 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2019-02-22 | 2019-02-26 | 11,479 | $82.11 | $942.5K | 21,332 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2019-02-22 | 2019-02-26 | 14,490 | $81.70 | $1.18M | 6,842 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2019-02-22 | 2019-02-26 | 510 | $82.25 | $41.9K | 6,332 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2019-01-17 | 2019-01-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2019-01-01 | 2019-01-03 | 155 | $64.41 | $10.0K | 6,332 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-10-01 | 2018-10-03 | 142 | $70.18 | $10.0K | 6,177 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-08-27 | 2018-08-28 | 12,500 | $100.00 | $1.25M | 130,167 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-08-24 | 2018-08-28 | 12,500 | $99.00 | $1.24M | 142,667 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-07-01 | 2018-07-03 | 198 | $50.40 | $10.0K | 6,035 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-06-14 | 2018-06-18 | 3,775 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-06-14 | 2018-06-18 | 2,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-06-14 | 2018-06-18 | 2,669 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-06-14 | 2018-06-18 | 20,681 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-06-14 | 2018-06-18 | 1,875 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-14 | 2018-06-18 | 2,000 | $90.00 | $180.0K | 155,167 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-06-14 | 2018-06-18 | 2,000 | $21.51 | $43.0K | 157,167 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-14 | 2018-06-18 | 20,681 | $90.00 | $1.86M | 155,167 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-06-14 | 2018-06-18 | 20,681 | $37.46 | $774.7K | 175,848 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-14 | 2018-06-18 | 1,875 | $90.00 | $168.8K | 155,167 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-06-14 | 2018-06-18 | 1,875 | $26.49 | $49.7K | 157,042 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-14 | 2018-06-18 | 2,669 | $90.00 | $240.2K | 155,167 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-06-14 | 2018-06-18 | 2,669 | $37.46 | $100.0K | 157,836 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-06-14 | 2018-06-18 | 3,775 | $26.49 | $100.0K | 158,942 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-14 | 2018-06-18 | 3,775 | $90.00 | $339.8K | 155,167 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2018-06-07 | 2018-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-06-04 | 2018-06-06 | 1,934 | $92.07 | $178.1K | 155,167 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-04-30 | 2018-06-06 | 309 | $68.78 | $21.3K | 157,101 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-04-02 | 2018-04-03 | 3,350 | — | $0 | 1,875 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-04-02 | 2018-04-03 | 6,650 | — | $0 | 20,681 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-04-02 | 2018-04-03 | 6,650 | $80.12 | $532.8K | 156,676 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-04-02 | 2018-04-03 | 3,350 | $80.12 | $268.4K | 156,676 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-04-02 | 2018-04-03 | 6,650 | $37.46 | $249.1K | 163,326 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-04-02 | 2018-04-03 | 3,350 | $26.49 | $88.7K | 160,026 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-04-01 | 2018-04-03 | 319 | $31.29 | $10.0K | 5,837 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-04-27 | 5,835 | $81.36 | $474.7K | 156,653 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-03-26 | 5,812 | $81.36 | $472.9K | 156,676 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2018-03-15 | 2018-03-19 | 51,300 | — | $0 | 51,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-15 | 2018-03-19 | 4,861 | $83.57 | $406.2K | 146,448 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-03-15 | 2018-03-19 | 16,040 | — | $0 | 162,488 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-02 | 2018-03-06 | 2,576 | $79.86 | $205.7K | 151,309 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-04-26 | 20,463 | — | $0 | 154,024 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-02-28 | 20,324 | — | $0 | 153,885 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2018-01-18 | 2018-01-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-01-02 | 2018-01-04 | 10,000 | — | $0 | 27,331 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-01-02 | 2018-01-04 | 5,000 | — | $0 | 5,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-01-02 | 2018-01-04 | 15,000 | $89.23 | $1.34M | 133,976 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-01-02 | 2018-01-04 | 10,000 | $37.46 | $374.6K | 148,976 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-01-02 | 2018-01-04 | 5,000 | $26.49 | $132.4K | 138,976 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2018-01-01 | 2018-01-03 | 292 | $34.20 | $10.0K | 5,518 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-10-01 | 2017-10-03 | 311 | $32.09 | $10.0K | 5,226 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-09-15 | 2017-09-19 | 5,000 | — | $0 | 10,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-09-15 | 2017-09-19 | 10,000 | — | $0 | 37,934 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-09-15 | 2017-09-19 | 15,000 | $90.50 | $1.36M | 136,422 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-09-15 | 2017-09-19 | 5,000 | $26.49 | $132.4K | 141,422 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-09-15 | 2017-09-19 | 10,000 | $37.46 | $374.6K | 151,422 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-07-01 | 2017-07-05 | 307 | $32.55 | $10.0K | 4,915 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-19 | 2017-06-20 | 603 | — | $0 | 47,331 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-19 | 2017-06-20 | 603 | $90.00 | $54.3K | 136,422 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-19 | 2017-06-20 | 603 | $37.46 | $22.6K | 137,025 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-16 | 2017-06-20 | 9,397 | — | $0 | 47,934 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-16 | 2017-06-20 | 5,000 | — | $0 | 15,225 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2017-06-16 | 2017-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-16 | 2017-06-20 | 5,000 | $90.00 | $450.0K | 145,819 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-16 | 2017-06-20 | 9,397 | $37.46 | $352.0K | 150,819 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-16 | 2017-06-20 | 5,000 | $26.49 | $132.4K | 141,422 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-16 | 2017-06-20 | 9,397 | $90.00 | $845.7K | 136,422 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-06-02 | 2017-06-06 | 2,036 | $90.72 | $184.7K | 136,422 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2017-05-17 | 2017-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-05-15 | 2017-05-17 | 2,036 | $91.50 | $186.3K | 138,458 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-04-28 | 2017-05-17 | 302 | $70.30 | $21.2K | 140,494 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-04-01 | 2017-04-04 | 317 | $31.49 | $10.0K | 4,608 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-03-22 | 2017-03-24 | 64,030 | — | $0 | 64,030 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-03-22 | 2017-03-24 | 19,790 | — | $0 | 140,192 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-15 | 2017-03-17 | 5,116 | $92.50 | $473.2K | 120,402 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-03 | 2017-03-07 | 2,924 | $93.95 | $274.7K | 125,518 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-02-24 | 2017-02-28 | 15,000 | — | $0 | 20,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-02-24 | 2017-02-28 | 15,000 | $26.49 | $397.4K | 143,442 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-02-24 | 2017-02-28 | 15,000 | $87.99 | $1.32M | 128,442 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-02-24 | 2017-02-28 | 14,564 | — | $0 | 128,442 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2017-01-01 | 2017-01-04 | 340 | $29.39 | $10.0K | 4,291 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-11-25 | 2016-11-29 | 15,000 | — | $0 | 35,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-11-25 | 2016-11-29 | 15,000 | $87.40 | $1.31M | 113,878 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-11-25 | 2016-11-29 | 15,000 | $26.49 | $397.4K | 128,878 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-10-01 | 2016-10-04 | 345 | $28.92 | $10.0K | 3,951 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-08-26 | 2016-08-30 | 15,000 | — | $0 | 50,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-08-26 | 2016-08-30 | 15,000 | $26.49 | $397.4K | 128,878 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-08-26 | 2016-08-30 | 15,000 | $95.06 | $1.43M | 113,878 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-07-01 | 2016-07-06 | 373 | $26.74 | $10.0K | 3,606 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2016-06-10 | 2016-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-06-03 | 2016-06-07 | 2,036 | $90.00 | $183.2K | 113,878 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-05-26 | 2016-05-31 | 15,000 | — | $0 | 65,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-26 | 2016-05-31 | 10,000 | $88.04 | $880.4K | 120,914 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-26 | 2016-05-31 | 5,000 | $87.34 | $436.7K | 115,914 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-05-26 | 2016-05-31 | 15,000 | $26.49 | $397.4K | 130,914 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-13 | 2016-05-17 | 2,036 | $82.71 | $168.4K | 115,914 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-06 | 2016-05-10 | 3,131 | $80.80 | $253.0K | 117,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-04-29 | 2016-05-10 | 415 | $51.26 | $21.3K | 121,081 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-04-01 | 2016-04-04 | 392 | $25.48 | $10.0K | 3,233 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-03-15 | 2016-03-17 | 44,340 | — | $0 | 44,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-03-15 | 2016-03-17 | 19,790 | — | $0 | 120,666 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-03-03 | 2016-03-07 | 3,043 | $89.57 | $272.6K | 100,876 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-02-29 | 2016-03-02 | 56,464 | $81.87 | $4.62M | 103,919 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 59,520 | — | $0 | 152,946 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 7,437 | — | $0 | 160,383 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 20,580 | — | $0 | 93,426 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2016-01-01 | 2016-01-05 | 284 | $35.20 | $10.0K | 2,841 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-10-01 | 2015-10-05 | 468 | $21.34 | $10.0K | 2,557 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-07-01 | 2015-07-06 | 365 | $27.34 | $10.0K | 2,089 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2015-06-12 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-06-05 | 2015-06-08 | 1,864 | $122.32 | $228.0K | 72,846 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-06-04 | 2015-06-08 | 2,036 | $120.46 | $245.3K | 74,710 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2015-05-21 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-18 | 2015-05-19 | 1,864 | $124.78 | $232.6K | 76,746 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-15 | 2015-05-19 | 2,036 | $122.78 | $250.0K | 78,610 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-13 | 2015-05-14 | 1,434 | $121.37 | $174.0K | 80,646 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-12 | 2015-05-14 | 1,566 | $121.09 | $189.6K | 82,080 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-11 | 2015-05-12 | 2,869 | $121.64 | $349.0K | 83,646 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-08 | 2015-05-12 | 3,131 | $121.66 | $380.9K | 86,515 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-01 | 2015-05-05 | 414 | $114.59 | $47.4K | 89,646 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-04-30 | 2015-05-05 | 1,425 | $51.26 | $73.0K | 90,060 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-04-01 | 2015-04-03 | 328 | $30.43 | $10.0K | 1,724 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-03-16 | 2015-03-18 | 34,155 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-03-16 | 2015-03-18 | 5,845 | — | $0 | 2,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-03-16 | 2015-03-18 | 34,155 | $21.51 | $734.7K | 124,105 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-03-16 | 2015-03-18 | 5,845 | $21.51 | $125.7K | 129,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-03-16 | 2015-03-18 | 41,315 | $123.57 | $5.11M | 88,635 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | J Other | 2015-03-03 | 2017-10-13 | 0 | — | $0 | 88,515 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-03-03 | 2015-03-05 | 30,500 | — | $0 | 30,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-03-03 | 2015-03-05 | 13,400 | — | $0 | 89,950 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2015-01-01 | 2015-01-05 | 312 | $31.97 | $10.0K | 1,396 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-11-10 | 2014-11-12 | 20,000 | — | $0 | 34,155 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-11-10 | 2014-11-12 | 20,000 | $21.51 | $430.2K | 96,550 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-11-10 | 2014-11-12 | 20,000 | $86.55 | $1.73M | 76,550 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2014-10-01 | 2014-10-03 | 350 | $28.54 | $10.0K | 1,084 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-09-09 | 2014-09-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-09-09 | 2014-09-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-09-09 | 2014-09-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-08-05 | 2014-08-07 | 10,000 | — | $0 | 54,155 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-08-05 | 2014-08-07 | 10,000 | $65.00 | $650.0K | 76,550 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-08-05 | 2014-08-07 | 10,000 | $21.51 | $215.1K | 86,550 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2014-07-01 | 2014-07-03 | 358 | $27.86 | $10.0K | 734 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2014-06-06 | 2014-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-06 | 58,400 | — | $0 | 58,400 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2014-06-06 | 15,600 | — | $0 | 76,550 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-16 | 2014-05-19 | 1,864 | $56.86 | $106.0K | 60,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-15 | 2014-05-19 | 2,036 | $57.44 | $116.9K | 62,814 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-13 | 2015-01-28 | 1,434 | $58.23 | $83.5K | 63,415 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-13 | 2014-05-14 | 1,434 | $58.23 | $83.5K | 64,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-12 | 2015-01-28 | 3,001 | $59.30 | $178.0K | 64,849 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-12 | 2014-05-14 | 1,566 | $59.30 | $92.9K | 66,284 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-09 | 2014-05-12 | 3,479 | $57.91 | $201.5K | 67,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-08 | 2014-05-12 | 2,521 | $56.78 | $143.1K | 71,329 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-01 | 2014-05-05 | 715 | $59.67 | $42.7K | 73,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-04-30 | 2014-05-05 | 715 | $29.69 | $21.2K | 74,565 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2014-04-01 | 2014-04-03 | 376 | $26.57 | $10.0K | 376 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-02-14 | 2014-02-19 | 31,500 | — | $0 | 73,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-02-03 | 2014-02-04 | 10,000 | — | $0 | 64,155 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-02-03 | 2014-02-04 | 10,000 | $67.70 | $677.0K | 42,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-02-03 | 2014-02-04 | 10,000 | $21.51 | $215.1K | 52,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-01-02 | 2014-01-06 | 916 | $68.97 | $63.2K | 42,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | D To issuer deriv | 2013-09-19 | 2013-09-23 | 10,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-09-19 | 2013-09-23 | 10,000 | $80.19 | $801.9K | 43,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-09-19 | 2013-09-23 | 10,000 | $11.05 | $110.5K | 53,266 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2013-09-17 | 2013-09-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | D To issuer deriv | 2013-09-05 | 2013-09-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-09-05 | 2013-09-09 | 10,000 | $70.00 | $700.0K | 43,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-09-05 | 2013-09-09 | 10,000 | $11.05 | $110.5K | 53,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | D To issuer deriv | 2013-07-01 | 2013-07-02 | 10,000 | — | $0 | 20,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-07-01 | 2013-07-02 | 10,000 | $11.05 | $110.5K | 53,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-07-01 | 2013-07-02 | 10,000 | $60.00 | $600.0K | 43,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-06-03 | 2013-06-05 | 1,098 | $58.32 | $64.0K | 43,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-23 | 2013-05-24 | 8,710 | $67.16 | $585.0K | 44,364 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | D To issuer deriv | 2013-05-22 | 2013-05-24 | 10,000 | — | $0 | 30,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-22 | 2013-05-24 | 11,899 | $65.66 | $781.3K | 53,074 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-22 | 2013-05-24 | 10,000 | $11.05 | $110.5K | 64,973 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 91,000 | — | $0 | 91,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 15,600 | — | $0 | 54,973 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-12 | 2013-05-14 | 3,001 | $67.68 | $203.1K | 39,373 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-08 | 2013-05-10 | 3,131 | $65.32 | $204.5K | 42,374 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-04-30 | 2013-05-01 | 20,000 | — | $0 | 40,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-04-30 | 2013-05-01 | 20,000 | $11.05 | $221.0K | 64,589 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-04-30 | 2013-05-01 | 20,000 | $63.29 | $1.27M | 44,589 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-04-30 | 2013-05-10 | 916 | $22.21 | $20.3K | 45,505 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-03-01 | 2013-03-04 | 1,908 | $59.61 | $113.7K | 44,589 | SEC↗ |